EU AI Act 2024: Complete Guide for Life Sciences
The European Union’s Artificial Intelligence Act represents the world’s first comprehensive legal framework for AI. For life sciences companies, understanding and preparing for these requirements is essential.Overview
The EU AI Act, officially adopted in 2024, establishes a risk-based approach to AI regulation. Medical devices and healthcare applications fall under high-risk categories, requiring stringent compliance measures.The AI Act will be phased in over 24-36 months, with some provisions taking effect as early as Q3 2024.
Key Requirements for Life Sciences
High-Risk AI Systems
AI systems used in medical devices and healthcare diagnostics are classified as high-risk and must comply with:- Data Governance: Implement robust data quality and management practices
- Technical Documentation: Maintain comprehensive records of AI system design and training
- Transparency: Provide clear information about AI capabilities and limitations
- Human Oversight: Ensure appropriate human supervision of AI decisions
- Accuracy & Robustness: Demonstrate consistent performance across diverse populations
Quality Management Systems
Companies must establish quality management systems that include:Impact Timeline
| Phase | Date | Requirements |
|---|---|---|
| Phase 1 | Aug 2024 | Prohibited AI practices banned |
| Phase 2 | May 2025 | General-purpose AI obligations |
| Phase 3 | Aug 2026 | High-risk system requirements |
| Phase 4 | Aug 2027 | Full implementation |
Preparing for Compliance
1
Assess Your AI Systems
Inventory all AI systems and classify them according to risk levels
2
Gap Analysis
Compare current practices against AI Act requirements
3
Implementation Plan
Develop a roadmap for achieving compliance
4
Documentation
Create and maintain required technical documentation
5
Training
Educate teams on AI Act requirements and procedures
Comeply’s AI Act Solution
Streamline AI Act Compliance
Learn how Comeply automates AI Act documentation and compliance management.
Additional Resources
- Official EU AI Act Text
- FDA Guidance on AI/ML-Based Medical Devices
- ISO 42001: AI Management Systems
This article is for informational purposes only and does not constitute legal advice. Consult with qualified legal counsel for specific compliance questions.
